{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:20Z","timestamp":1792788320138,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["No.2023AFB734"],"award-info":[{"award-number":["No.2023AFB734"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Research support fund of Hubei Microcirculation Society","award":["HBWXH2024(1)-1"],"award-info":[{"award-number":["HBWXH2024(1)-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-024-00555-1","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:50:29Z","timestamp":1731045029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["TRIM47 drives gastric cancer cell proliferation and invasion by regulating CYLD protein stability"],"prefix":"10.1186","volume":"19","author":[{"given":"Jianguo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"3","key":"555_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"555_CR2","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/ijms21114012","volume":"21","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012. https:\/\/doi.org\/10.3390\/ijms21114012. Published 2020 Jun 4.","journal-title":"Int J Mol Sci"},{"key":"555_CR3","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer, Statistics. 2021 [published correction appears in CA Cancer J Clin. 2021;71(4):359. https:\/\/doi.org\/10.3322\/caac.21669]. CA Cancer J Clin. 2021;71(1):7\u201333. doi: https:\/\/doi.org\/10.3322\/caac.21654.","DOI":"10.3322\/caac.21669 10.3322\/caac.21654"},{"key":"555_CR4","doi-asserted-by":"publisher","unstructured":"Shan C, Zhang Y, Hao X, Gao J, Chen X, Wang K. Biogenesis, functions and clinical significance of circRNAs in gastric cancer. Mol Cancer. 2019;18(1):136. Published 2019 Sep 13. https:\/\/doi.org\/10.1186\/s12943-019-1069-0","DOI":"10.1186\/s12943-019-1069-0"},{"issue":"1","key":"555_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3. Published 2023 May 27.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"555_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41(10):1037\u201348. https:\/\/doi.org\/10.1002\/cac2.12197.","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"555_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12094-021-02715-5","volume":"24","author":"A Mohammadi","year":"2022","unstructured":"Zhao G, et al. The translational values of TRIM family in pan-cancers: from functions and mechanisms to clinics. Pharmacol Ther. 2021;227:107881. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107881.","journal-title":"Clin Transl Oncol"},{"key":"555_CR8","doi-asserted-by":"publisher","unstructured":"Huang N, et al. TRIMfamily contribute to tumorigenesis, cancer development, and drug resistance. Exp Hematol Oncol. 2022;11:75. https:\/\/doi.org\/10.1186\/s40164-022-00322-w","DOI":"10.1186\/s40164-022-00322-w"},{"issue":"11","key":"555_CR9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/bies.20304","volume":"27","author":"G Meroni","year":"2005","unstructured":"Gu J, Chen J, Xiang S, Zhou X, Li J. Intricate confrontation: research progress and application potential of TRIMfamily proteins in tumor immune escape. J Adv Res. 2023;54:147\u201379. https:\/\/doi.org\/10.1016\/j.jare.2023.01.011","journal-title":"BioEssays"},{"issue":"10","key":"555_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrmicro1248","volume":"3","author":"S Nisole","year":"2005","unstructured":"Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. 2017;42:297\u2013311. https:\/\/doi.org\/10.1016\/j.tibs.2017.01.002.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"555_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1006\/bbrc.2001.5431","volume":"286","author":"DA Vandeputte","year":"2001","unstructured":"Vandeputte DA, Meije CB, van Dartel M, et al. GOA, a novel gene encoding a ring finger B-box coiled-coil protein, is overexpressed in astrocytoma. Biochem Biophys Res Commun. 2001;286(3):574\u20139. https:\/\/doi.org\/10.1006\/bbrc.2001.5431.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"555_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bbrc.2019.05.065","volume":"515","author":"MQ Hao","year":"2019","unstructured":"Hao MQ, Xie LJ, Leng W, Xue RW. Trim47 is a critical regulator of cerebral ischemia-reperfusion injury through regulating apoptosis and inflammation. Biochem Biophys Res Commun. 2019;515(4):651\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2019.05.065.","journal-title":"Biochem Biophys Res Commun"},{"key":"555_CR13","doi-asserted-by":"publisher","unstructured":"Qian Y, Wang Z, Lin H et al. TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2. Signal Transduct Target Ther. 2022;7(1):148. Published 2022 May 6. https:\/\/doi.org\/10.1038\/s41392-022-00953-9","DOI":"10.1038\/s41392-022-00953-9"},{"issue":"35","key":"555_CR14","doi-asserted-by":"publisher","first-page":"e2100784118","DOI":"10.1073\/pnas.2100784118","volume":"118","author":"K Azuma","year":"2021","unstructured":"Azuma K, Ikeda K, Suzuki T, Aogi K, Horie-Inoue K, Inoue S. TRIM47 activates NF-\u03baB signaling via PKC-\u03b5\/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer. Proc Natl Acad Sci U S A. 2021;118(35):e2100784118. https:\/\/doi.org\/10.1073\/pnas.2100784118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"555_CR15","doi-asserted-by":"publisher","first-page":"105429","DOI":"10.1016\/j.phrs.2021.105429","volume":"166","author":"L Li","year":"2021","unstructured":"Li L, Yu Y, Zhang Z, et al. TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer. Pharmacol Res. 2021;166:105429. https:\/\/doi.org\/10.1016\/j.phrs.2021.105429.","journal-title":"Pharmacol Res"},{"issue":"14","key":"555_CR16","doi-asserted-by":"publisher","first-page":"22730","DOI":"10.18632\/oncotarget.15188","volume":"8","author":"Y Han","year":"2017","unstructured":"Han Y, Tian H, Chen P, Lin Q. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma. Oncotarget. 2017;8(14):22730\u201340. https:\/\/doi.org\/10.18632\/oncotarget.15188.","journal-title":"Oncotarget"},{"issue":"6","key":"555_CR17","doi-asserted-by":"publisher","first-page":"e13423","DOI":"10.1111\/cpr.13423","volume":"56","author":"D Li","year":"2023","unstructured":"Qin S, et al. lncRNA FGD5-AS1 is required for gastric cancer proliferation byinhibiting cell senescence and ROS production via stabilizing YBX1. J Exp Clin Cancer Res. 2024;43:188. https:\/\/doi.org\/10.1186\/s13046-024-03103-x.","journal-title":"Cell Prolif"},{"key":"555_CR18","doi-asserted-by":"publisher","unstructured":"Li D, et al. Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: focusing on partial EMT and regulatory mechanisms. Cell Prolif. 2023;56:e13423. https:\/\/doi.org\/10.1111\/cpr.13423.","DOI":"10.1111\/cpr.13423"},{"issue":"1","key":"555_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12935-021-01831-0","volume":"21","author":"JX Chen","year":"2021","unstructured":"Chen JX, Xu D, Cao JW, et al. TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination. Cancer Cell Int. 2021;21(1):129. https:\/\/doi.org\/10.1186\/s12935-021-01831-0. Published 2021 Feb 23.","journal-title":"Cancer Cell Int"},{"key":"555_CR20","doi-asserted-by":"publisher","first-page":"13401","DOI":"10.2147\/OTT.S264459","volume":"13","author":"H Wei","year":"2020","unstructured":"Wei H, Ding C, Zhuang H, Hu W. TRIM47 promotes the development of glioma by Ubiquitination and Degradation of FOXO1. Onco Targets Ther. 2020;13:13401\u201311. https:\/\/doi.org\/10.2147\/OTT.S264459. Published 2020 Dec 31.","journal-title":"Onco Targets Ther"},{"key":"555_CR21","doi-asserted-by":"publisher","first-page":"108960","DOI":"10.1016\/j.cbi.2020.108960","volume":"317","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu C, Xie Z, Lu H. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K\/Akt pathway. Chem Biol Interact. 2020;317:108960. https:\/\/doi.org\/10.1016\/j.cbi.2020.108960.","journal-title":"Chem Biol Interact"},{"key":"555_CR22","doi-asserted-by":"publisher","unstructured":"Liu F, Xie B, Ye R et al. Overexpression of tripartite motif-containing 47 (TRIM47) confers sensitivity to PARP inhibition via ubiquitylation of BRCA1 in triple negative breast cancer cells. Oncogenesis. 2023;12(1):13. Published 2023 Mar 11. https:\/\/doi.org\/10.1038\/s41389-023-00453-7","DOI":"10.1038\/s41389-023-00453-7"},{"key":"555_CR23","doi-asserted-by":"publisher","unstructured":"Dong D, et al. Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance. Drug Resist Updat. 2024;77:101125. https:\/\/doi.org\/10.1016\/j.drup.2024.101125.","DOI":"10.1016\/j.drup.2024.101125"},{"key":"555_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2024.04.001","volume":"101","author":"YE Zhang","year":"2024","unstructured":"Zhang YE, Stuelten CH. Alternative splicing in EMT and TGF-\u03b2 signaling during cancer progression. Semin Cancer Biol. 2024;101:1\u201311. https:\/\/doi.org\/10.1016\/j.semcancer.2024.04.001.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"555_CR25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1189\/jlb.0310153","volume":"88","author":"SK Biswas","year":"2010","unstructured":"Baud, V. & Karin, M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov. 2009;8:33\u201340. https:\/\/doi.org\/10.1038\/nrd2781.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"555_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/biomedicines5030050","volume":"5","author":"F Begalli","year":"2017","unstructured":"Sun, S.-C. The non-canonical NF-\u03baB pathway inimmunity and inflammation. Nat Rev Immunol. 2017;17:545\u201358. https:\/\/doi.org\/10.1038\/nri.2017.52.","journal-title":"Biomedicines"},{"issue":"12","key":"555_CR27","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.biocel.2012.08.002","volume":"44","author":"M Moretti","year":"2012","unstructured":"Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25:280\u20138.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"555_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","volume":"21","author":"SC Sun","year":"2011","unstructured":"Taniguchi K, Karin, M. NF-\u03baB, inflammation, immunity andcancer: coming of age. Nat Rev Immunol2018;18:309\u2013324. https:\/\/doi.org\/10.1038\/nri.2017.142.","journal-title":"Cell Res"},{"issue":"3","key":"555_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","volume":"26","author":"MS Hayden","year":"2012","unstructured":"Hayden MS, Ghosh S. NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012;26(3):203\u201334. https:\/\/doi.org\/10.1101\/gad.183434.111.","journal-title":"Genes Dev"},{"key":"555_CR30","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"555_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10549-013-2824-3","volume":"143","author":"M Hayashi","year":"2014","unstructured":"Hayashi M, Jono H, Shinriki S, et al. Clinical significance of CYLD downregulation in breast cancer. Breast Cancer Res Treat. 2014;143(3):447\u201357. https:\/\/doi.org\/10.1007\/s10549-013-2824-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"6950","key":"555_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nature01803","volume":"424","author":"E Trompouki","year":"2003","unstructured":"Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003;424(6950):793\u20136. https:\/\/doi.org\/10.1038\/nature01803.","journal-title":"Nature"},{"issue":"12","key":"555_CR33","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1084\/jem.20031187","volume":"198","author":"A Regamey","year":"2003","unstructured":"Regamey A, Hohl D, Liu JW, et al. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor. J Exp Med. 2003;198(12):1959\u201364. https:\/\/doi.org\/10.1084\/jem.20031187.","journal-title":"J Exp Med"},{"issue":"1","key":"555_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41420-023-01760-z","volume":"9","author":"J Chen","year":"2023","unstructured":"Liu F, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to noveltherapeutic approaches. Mol Cancer. 2024;23:148. https:\/\/doi.org\/10.1186\/s12943-024-02046-3.","journal-title":"Cell Death Discov"},{"issue":"1","key":"555_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","volume":"2","author":"Q Yang","year":"2021","unstructured":"Mani A, Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol. 2005;23:4776\u201389.","journal-title":"Mol Biomed"},{"issue":"12","key":"555_CR36","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-023-06332-8","volume":"14","author":"W Yang","year":"2023","unstructured":"Yang W, Cui X, Sun D, et al. POU5F1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6. Cell Death Dis. 2023;14(12):802. https:\/\/doi.org\/10.1038\/s41419-023-06332-8. Published 2023 Dec 7.","journal-title":"Cell Death Dis"},{"key":"555_CR37","doi-asserted-by":"publisher","first-page":"216510","DOI":"10.1016\/j.canlet.2023.216510","volume":"581","author":"T Jiang","year":"2024","unstructured":"Jiang T, Xia Y, Li Y, et al. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer. Cancer Lett. 2024;581:216510. https:\/\/doi.org\/10.1016\/j.canlet.2023.216510.","journal-title":"Cancer Lett"},{"key":"555_CR38","doi-asserted-by":"publisher","unstructured":"Feng Q, Nie F, Gan L et al. Tripartite motif 31 drives gastric cancer cell proliferation and invasion through activating the Wnt\/\u03b2-catenin pathway by regulating Axin1 protein stability. Sci Rep. 2023;13(1):20099. Published 2023 Nov 16. https:\/\/doi.org\/10.1038\/s41598-023-47139-z","DOI":"10.1038\/s41598-023-47139-z"},{"issue":"1","key":"555_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2009.01.041","volume":"137","author":"P Xu","year":"2009","unstructured":"Xu P, Duong DM, Seyfried NT, et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell. 2009;137(1):133\u201345. https:\/\/doi.org\/10.1016\/j.cell.2009.01.041.","journal-title":"Cell"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00555-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-024-00555-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00555-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:04:15Z","timestamp":1731045855000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-024-00555-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1186\/s13062-024-00555-1","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Renmin Hospital of Wuhan University and the Animal Research Ethics Committees at Renmin Hospital of Wuhan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}